| 7384934 |
Piperazine substituted aryl benzodiazepines |
Thomas D. Aicher, Zhaogen Chen, Yvan LeHuerou, Fionna Mitchell Martin, Marta Pineiro-Nunez +4 more |
2008-06-10 |
$65,113,000 |
| 7214673 |
Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders |
Thomas D. Aicher, Zhaogen Chen, Joseph H. Krushinski, Jr., Yvan Le Huerou, Marta Pineiro-Nunez +6 more |
2007-05-08 |
$92,297,000 |
| 7208505 |
β3 adrenergic agonists |
Daniel Jon Sall, Jolie Anne Bastian, Rushad E. Karanjawala, Cynthia Darshini Jesudason, Theo Schotten +9 more |
2007-04-24 |
$185,204,000 |
| 7144898 |
Indole derivatives for the treatment of depression and anxiety |
Marvin M. Hansen, John Xiaoqiang He, Nicholas Allan Honigschmidt, Daniel James Koch, Todd J. Kohn +2 more |
2006-12-05 |
$65,374,000 |
| 7087635 |
3-substituted oxindole β3 agonists |
Daniel Jon Sall, Jolie Anne Bastian, Cynthia Darshini Jesudason, Don Richard Finley, Freddie Craig Stevens +7 more |
2006-08-08 |
$73,993,000 |
| 6911463 |
3-substituted oxindole β-3 agonists |
Daniel Jon Sall, Jolie Anne Bastian, Cynthia Darshini Jesudason, Theo Schotten, Gerd Reuhter +7 more |
2005-06-28 |
$155,390,000 |
| 6844344 |
Benzofuran derivatives |
John Xiaoqiang He, Nicholas Allan Honigschmidt, Todd J. Kohn, Patrick Gianpietro Spinazze, Kumiko Takeuchi |
2005-01-18 |
$148,156,000 |
| 6835733 |
Tropane linked benzofuran derivatives |
John Xiaoqiang He, Nicholas Allan Honigschmidt, Todd J. Kohn, Patrick Gianpietro Spinazze, Kumiko Takeuchi |
2004-12-28 |
$151,621,000 |
| 6784180 |
Piperidines derivatives and their use as serotonin receptor antagonists |
John Xiaoqiang He, Nicholas Allan Honigschmidt, Todd J. Kohn, Patrick Gianpietro Spinazze, Kumiko Takeuchi |
2004-08-31 |
$188,799,000 |
| 6376505 |
5-HT1A and 5-HT1D&agr;dalpha antagonists |
— |
2002-04-23 |
$207,632,000 |
| 6358972 |
5-HT1F agonists |
Sandra Ann Filla, Daniel James Koch, Brian Michael Mathes |
2002-03-19 |
$63,225,000 |
| 6303627 |
Inhibitors of serotonin reuptake |
Daniel James Koch |
2001-10-16 |
$145,417,000 |
| 6242450 |
5-HT1F antagonists |
Daniel James Koch, Lee A. Phebus, Tammy Joy Sajdyk |
2001-06-05 |
$240,697,000 |
| 6172073 |
Compounds having effects on serotonin-related systems |
James E. Audia, David J. Hibschman, Joseph H. Krushinski, Jr., Thomas E. Mabry, Jeffrey S. Nissen +4 more |
2001-01-09 |
$400,731,000 |
| 6150375 |
5.alpha.-reductase inhibitors |
James E. Audia, Loretta A. McQuaid, Blake L. Neubauer, Kevin L. Haehl, Thomas J. Kress +1 more |
2000-11-21 |
$434,814,000 |
| 6046215 |
Inhibition of serotonin reuptake |
James E. Audia, Daniel James Koch, Thomas E. Mabry, Jeffrey S. Nissen, Yao-Chang Xu |
2000-04-04 |
$216,653,000 |
| 5962474 |
5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)-and 3-(piperidin-4-yl)-1h-indoles: 5-HT.sub.1F agonists |
James E. Audia, Bruce A. Dressman, James J. Droste, James E. Fritz, Stephen W. Kaldor +5 more |
1999-10-05 |
$103,905,000 |
| 5912256 |
Compounds having effects on serotonin-related systems |
Daniel James Koch |
1999-06-15 |
$153,165,000 |
| 5846982 |
Inhibition of serotonin reuptake |
James E. Audia, Daniel James Koch, Thomas E. Mabry, Jeffrey S. Nissen, Yao-Chang Xu |
1998-12-08 |
$178,932,000 |
| 5789402 |
Compounds having effects on serotonin-related systems |
James E. Audia, David J. Hibschman, Joseph H. Krushinski, Jr., Thomas E. Mabry, Jeffrey S. Nissen +4 more |
1998-08-04 |
$190,565,000 |
| 5741789 |
Compounds having effects on serotonin-related systems |
David J. Hibschman, Joseph H. Krushinski, Jr., Kurt Rasmussen, John M. Schaus, Dennis C. Thompson |
1998-04-21 |
$545,957,000 |
| 5708008 |
5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)-and 3-(piperidin-4-yl)-1H-indoles: new 5-HT.sub.1F agonists |
James E. Audia, Bruce A. Dressman, James J. Droste, James E. Fritz, Stephen W. Kaldor +5 more |
1998-01-13 |
$65,836,000 |
| 5627196 |
Compounds having effects on serotonin-related systems |
James E. Audia, David J. Hibschman, Joseph H. Krushinski, Jr., Thomas E. Mabry, Jeffrey S. Nissen +4 more |
1997-05-06 |
$147,623,000 |
| 5622961 |
5.alpha.-reductase inhibitors |
James E. Audia, Loretta A. McQuaid, Blake L. Neubauer |
1997-04-22 |
$48,998,000 |
| 5622962 |
5.alpha.-reductase inhibitors |
James E. Audia, Loretta A. McQuaid, Blake L. Neubauer |
1997-04-22 |
$48,998,000 |
